Regenerative Medicine and Stem Cells Technologies

Researchers at Tohoku University have revealed further insight into the fetal development of our brain and the potential causes of fragile X syndrome (FSX).

Over two million babies, children, and adults in the United States are living with congenital heart disease—a range of birth defects affecting the heart's structure or function.

An international research led by the Complutense University of Madrid has taken a further step to solve the age-related macular degeneration (AMD)-derived blidness problem with the development of the first biohybrid artificial retina built with silk fibroin and retinal cells.

Many neurodegenerative conditions, from glaucoma to Alzheimer's disease, are characterized by injury to axons—the long, slender projections that conduct electrical impulses from one nerve cell to another, facilitating cellular communications. Injury to axons often leads to neuronal impairment and cell death.

In a new Phase I clinical trial, scientists from Odense University Hospital (Denmark) have shown that adipose-derived stem cells could be used to treat lymphedema – a chronic condition that typically causes swelling in the arms or legs.

Yale scientists have identified a crucial biological link in the process that transforms certain complex sugars into hematopoietic stem and progenitor cells.

Worldwide, cancer is the second leading cause of death—in 2018 alone, it claimed approximately 9.6 million lives, or one in six deaths. The development of cancer is incredibly complex and is controlled by an interplay of various factors—only recently, it became clear that the majority of human cancers such as cervical, gastrointestinal and breast among others, originate from adult stem cells becoming deregulated.